2026 Q1 Portfolio Activity
In 2026 Q1, Tetragon Partners GP Ltd maintained a portfolio of 40 distinct positions. The most significant new addition was WARNER BROS DISCOVERY INC, now representing 4.92% of the total fund value. They heavily accumulated shares in NEKTAR THERAPEUTICS, increasing the position by 48.7%. Conversely, Tetragon Partners GP Ltd completely exited their position in RAPT THERAPEUTICS INC.
Position History
hover any row below to update
Loading…
Total Positions
40
Quarter
2026 Q1
Top Holding
PATH (54.3%)
Top 10 Concentration
82.0%
Turnover Rate
23.4%
Sector HHI
0.18
Items per page:
Showing 1-40 of 40
Tetragon Partners GP Ltd Full Holdings List — 2026 Q1
| Stock | History | Sector / Type | Port % | Prev % | Rank / Prev | Conviction | Change | % Change | Influence | Shares | Mkt Value | Avg Cost | Price Held | 1st Owned | Source | Source Date | Date Reported | |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
|
PATH
UIPATH INC
|
Technology | 54.32% | 60.30% |
#1
Prev: #1
|
8.5 |
—
|
7,757,628 | 44.5% |
P
S
|
25,207,628 | $279,804,671 | 2022 Q1 | 13F Filing | 2026-03-31 | 2026-05-15 | |||
|
KGEI
KOLIBRI GLOBAL ...
|
Energy | 7.28% | 5.75% |
#2
Prev: #2
|
4.9 |
—
|
-100,000 | -1.4% |
P
S
|
6,834,504 | $37,521,427 | 2023 Q4 | 13F Filing | 2026-03-31 | 2026-05-15 | |||
|
WBD
WARNER BROS DIS...
|
Communication Services | 4.92% | — |
#3
Prev: #—
|
6.5 |
—
|
923,725 | — |
NEW
|
923,725 | $25,365,489 | 2026 Q1 | 13F Filing | 2026-03-31 | 2026-05-15 | |||
|
WK
WORKIVA INC
|
Technology | 2.89% | 2.73% |
#4
2
Prev: #6
|
4.7 |
—
|
100,000 | 66.7% |
P
S
|
250,000 | $14,907,500 | 2025 Q2 | 13F Filing | 2026-03-31 | 2026-05-15 | |||
|
LYFT
LYFT INC
|
Technology | 2.58% | 4.08% |
#5
2
Prev: #3
|
2.5 |
—
|
no change | no change |
P
S
|
1,000,000 | $13,300,000 | 2019 Q3 | 13F Filing | 2026-03-31 | 2026-05-15 | |||
|
CXM
SPRINKLR INC
|
Technology | 2.56% | 3.61% |
#6
1
Prev: #5
|
2.0 |
—
|
no change | no change |
P
S
|
2,200,000 | $13,200,000 | 2022 Q1 | 13F Filing | 2026-03-31 | 2026-05-15 | |||
|
AUTL
AUTOLUS THERAPE...
|
Healthcare | 2.55% | 3.99% |
#7
3
Prev: #4
|
2.0 |
—
|
no change | no change |
P
S
|
9,500,000 | $13,110,000 | 2018 Q2 | 13F Filing | 2026-03-31 | 2026-05-15 | |||
|
CLDX
CELLDEX THERAPE...
|
Healthcare | 1.92% | 1.40% |
#8
1
Prev: #9
|
3.3 |
—
|
68,516 | 28.1% |
P
S
|
312,316 | $9,906,664 | 2024 Q4 | 13F Filing | 2026-03-31 | 2026-05-15 | |||
|
ARWR
ARROWHEAD PHARM...
|
Healthcare | 1.55% | 1.36% |
#9
1
Prev: #10
|
3.1 |
—
|
30,263 | 31.2% |
P
S
|
127,198 | $7,975,315 | 2025 Q3 | 13F Filing | 2026-03-31 | 2026-05-15 | |||
|
NKTR
NEKTAR THERAPEU...
|
Healthcare | 1.44% | 0.62% |
#10
12
Prev: #22
|
3.1 |
—
|
33,750 | 48.7% |
P
S
|
103,037 | $7,413,512 | 2025 Q4 | 13F Filing | 2026-03-31 | 2026-05-15 | |||
|
ANNX
ANNEXON INC
|
Healthcare | 1.39% | 2.15% |
#11
4
Prev: #7
|
0.6 |
—
|
-740,000 | -36.4% |
P
S
|
1,292,455 | $7,160,201 | 2024 Q2 | 13F Filing | 2026-03-31 | 2026-05-15 | |||
|
PHVS
PHARVARIS N V
|
Healthcare | 1.22% | 1.14% |
#12
1
Prev: #11
|
2.5 |
—
|
26,999 | 13.9% |
P
S
|
221,611 | $6,260,511 | 2025 Q1 | 13F Filing | 2026-03-31 | 2026-05-15 | |||
|
AXSM
CALL
AXSOME THERAPEU...
|
CALL Option | 1.15% | — |
#13
Prev: #—
|
4.0 |
—
|
35,000 | — |
NEW
|
35,000 | $5,915,700 | 2024 Q4 | 13F Filing | 2026-03-31 | 2026-05-15 | |||
|
ALKS
ALKERMES PLC
|
Healthcare | 1.10% | 0.83% |
#14
4
Prev: #18
|
2.4 |
—
|
18,619 | 13.2% |
P
S
|
159,791 | $5,650,210 | 2025 Q2 | 13F Filing | 2026-03-31 | 2026-05-15 | |||
|
AGIO
AGIOS PHARMACEU...
|
Healthcare | 1.08% | 0.93% |
#15
1
Prev: #16
|
0.9 |
—
|
2,821 | 1.7% |
P
S
|
164,839 | $5,576,503 | 2025 Q4 | 13F Filing | 2026-03-31 | 2026-05-15 | |||
|
IMVT
IMMUNOVANT INC
|
Healthcare | 1.05% | 0.89% |
#16
1
Prev: #17
|
2.9 |
—
|
52,320 | 31.5% |
P
S
|
218,507 | $5,427,714 | 2025 Q1 | 13F Filing | 2026-03-31 | 2026-05-15 | |||
|
PRAX
PRAXIS PRECISIO...
|
Healthcare | 1.00% | 1.43% |
#17
9
Prev: #8
|
0.4 |
—
|
-7,000 | -30.5% |
P
S
|
15,952 | $5,139,575 | 2025 Q4 | 13F Filing | 2026-03-31 | 2026-05-15 | |||
|
KRYS
KRYSTAL BIOTECH...
|
Healthcare | 0.99% | 0.61% |
#18
5
Prev: #23
|
3.4 |
—
|
7,854 | 66.5% |
P
S
|
19,668 | $5,080,638 | 2025 Q3 | 13F Filing | 2026-03-31 | 2026-05-15 | |||
|
DYN
DYNE THERAPEUTI...
|
Healthcare | 0.91% | 1.02% |
#19
6
Prev: #13
|
0.9 |
—
|
10,135 | 4.1% |
P
S
|
258,132 | $4,679,933 | 2025 Q2 | 13F Filing | 2026-03-31 | 2026-05-15 | |||
|
AMLX
AMYLYX PHARMACE...
|
Healthcare | 0.86% | 0.69% |
#20
Prev: #20
|
2.3 |
—
|
45,049 | 16.5% |
P
S
|
317,877 | $4,418,490 | 2025 Q2 | 13F Filing | 2026-03-31 | 2026-05-15 | |||
|
MBX
MBX BIOSCIENCES...
|
Healthcare | 0.84% | 0.95% |
#21
7
Prev: #14
|
0.8 |
—
|
2,153 | 1.5% |
P
S
|
145,480 | $4,342,578 | 2025 Q3 | 13F Filing | 2026-03-31 | 2026-05-15 | |||
|
DFTX
DEFINIUM THERAP...
|
Healthcare | 0.73% | — |
#22
Prev: #—
|
3.8 |
—
|
199,994 | — |
NEW
|
199,994 | $3,779,887 | 2026 Q1 | 13F Filing | 2026-03-31 | 2026-05-15 | |||
|
SLNO
SOLENO THERAPEU...
|
Healthcare | 0.66% | — |
#23
Prev: #—
|
3.8 |
—
|
102,125 | — |
NEW
|
102,125 | $3,419,145 | 2026 Q1 | 13F Filing | 2026-03-31 | 2026-05-15 | |||
|
AXSM
AXSOME THERAPEU...
|
Healthcare | 0.66% | 1.04% |
#24
12
Prev: #12
|
0.3 |
—
|
-6,875 | -25.5% |
P
S
|
20,059 | $3,390,372 | 2024 Q4 | 13F Filing | 2026-03-31 | 2026-05-15 | |||
|
HRMY
HARMONY BIOSCIE...
|
Healthcare | 0.65% | 0.65% |
#25
4
Prev: #21
|
2.8 |
—
|
36,516 | 44.1% |
P
S
|
119,340 | $3,342,713 | 2025 Q4 | 13F Filing | 2026-03-31 | 2026-05-15 | |||
|
SLN
SILENCE THERAPE...
|
Healthcare | 0.64% | 0.47% |
#26
1
Prev: #25
|
3.3 |
—
|
264,792 | 72.5% |
P
S
|
630,161 | $3,320,948 | 2025 Q4 | 13F Filing | 2026-03-31 | 2026-05-15 | |||
|
ACAD
ACADIA PHARMACE...
|
Healthcare | 0.62% | — |
#27
Prev: #—
|
3.7 |
—
|
144,620 | — |
NEW
|
144,620 | $3,219,241 | 2025 Q1 | 13F Filing | 2026-03-31 | 2026-05-15 | |||
|
IONS
IONIS PHARMACEU...
|
Healthcare | 0.61% | — |
#28
Prev: #—
|
3.7 |
—
|
41,764 | — |
NEW
|
41,764 | $3,136,059 | 2026 Q1 | 13F Filing | 2026-03-31 | 2026-05-15 | |||
|
MPLT
MAPLIGHT THERAP...
|
Healthcare | 0.44% | 0.61% |
#29
5
Prev: #24
|
0.2 |
—
|
-52,410 | -31.9% |
P
S
|
112,115 | $2,279,298 | 2025 Q4 | 13F Filing | 2026-03-31 | 2026-05-15 | |||
|
RLAY
RELAY THERAPEUT...
|
Healthcare | 0.35% | — |
#30
Prev: #—
|
3.6 |
—
|
181,543 | — |
NEW
|
181,543 | $1,806,353 | 2025 Q1 | 13F Filing | 2026-03-31 | 2026-05-15 | |||
|
SNOW
SNOWFLAKE INC
|
Technology | 0.29% | 0.46% |
#31
5
Prev: #26
|
1.1 |
—
|
no change | no change |
P
S
|
10,000 | $1,508,200 | 2020 Q3 | 13F Filing | 2026-03-31 | 2026-05-15 | |||
|
AARD
AARDVARK THERAP...
|
Healthcare | 0.23% | — |
#32
Prev: #—
|
3.6 |
—
|
316,621 | — |
NEW
|
316,621 | $1,193,661 | 2026 Q1 | 13F Filing | 2026-03-31 | 2026-05-15 | |||
|
TECX
TECTONIC THERAP...
|
Healthcare | 0.23% | — |
#33
Prev: #—
|
3.6 |
—
|
37,588 | — |
NEW
|
37,588 | $1,161,845 | 2025 Q1 | 13F Filing | 2026-03-31 | 2026-05-15 | |||
|
RARE
ULTRAGENYX PHAR...
|
Healthcare | 0.16% | — |
#34
Prev: #—
|
3.6 |
—
|
39,473 | — |
NEW
|
39,473 | $826,959 | 2025 Q3 | 13F Filing | 2026-03-31 | 2026-05-15 | |||
|
KPTI
KARYOPHARM THER...
|
Healthcare | 0.06% | — |
#35
Prev: #—
|
3.5 |
—
|
52,984 | — |
NEW
|
52,984 | $295,121 | 2026 Q1 | 13F Filing | 2026-03-31 | 2026-05-15 | |||
|
KPTI
CALL
KARYOPHARM THER...
|
CALL Option | 0.05% | — |
#36
Prev: #—
|
3.5 |
—
|
50,000 | — |
NEW
|
50,000 | $278,500 | 2026 Q1 | 13F Filing | 2026-03-31 | 2026-05-15 | |||
|
AVDL
AVADEL PHARMACE...
|
Unknown | 0.00% | 0.20% |
Sold All 😨
(Was: #28) |
0.0 |
—
|
-43,763 | -100.0% |
CLOSED
|
— | $— | 2025 Q4 | 13F Filing | 2026-03-31 | 2026-05-15 | |||
|
ZVRA
ZEVRA THERAPEUT...
|
Healthcare | 0.00% | 0.36% |
Sold All 😨
(Was: #27) |
0.0 |
—
|
-192,518 | -100.0% |
CLOSED
|
— | $— | 2025 Q4 | 13F Filing | 2026-03-31 | 2026-05-15 | |||
|
FOLD
AMICUS THERAPEU...
|
Healthcare | 0.00% | 0.78% |
Sold All 😨
(Was: #19) |
0.0 |
—
|
-260,771 | -100.0% |
CLOSED
|
— | $— | 2025 Q3 | 13F Filing | 2026-03-31 | 2026-05-15 | |||
|
RAPT
RAPT THERAPEUTI...
|
Healthcare | 0.00% | 0.94% |
Sold All 😨
(Was: #15) |
0.0 |
—
|
-131,770 | -100.0% |
CLOSED
|
— | $— | 2025 Q4 | 13F Filing | 2026-03-31 | 2026-05-15 |
Showing 1-40 of 40 holdings